Baseline prostate specific antigen does not affect the efficacy of tamsulosin in patients with lower urinary tract symptoms/benign prostatic hyperplasia

By Speakman M.J.   Snijder J.R.   Anthonijs G.L.   Doyle C.A.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 159-159

Elsevier

Access to resources Recommend Favorite

Identifying Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) at Risk for Progression

By Jimenez-Cruz F.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 6-12

Elsevier

Access to resources Recommend Favorite

Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management

By O'Leary M.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 25-33

Elsevier

Access to resources Recommend Favorite

The Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management: Introduction and Conclusions

By Chapple C.R.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 1-5

Elsevier

Access to resources Recommend Favorite

Impact of Therapy Used in Clinical Practice on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Disease Progression

By Berges R.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 19-24

Elsevier

Access to resources Recommend Favorite